Antibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations
- Western blot [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN152885 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Phospholipid Transfer Protein (PLTP) antibody
- Antibody type
- Polyclonal
- Description
- Unpurified
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Vial size
- 0.2 mL
- Storage
- Aliquot and store at -20°C or -80°C. Avoid freeze-thaw cycles.
- Handling
- Avoid freeze-thaw cycles
Submitted references Inactivation of Tm6sf2, a Gene Defective in Fatty Liver Disease, Impairs Lipidation but Not Secretion of Very Low Density Lipoproteins.
Plasma phospholipid transfer protein, cholesteryl ester transfer protein and lecithin:cholesterol acyltransferase in end-stage renal disease (ESRD).
Control of cholesteryl ester transfer protein activity by sequestration of lipid transfer inhibitor protein in an inactive complex.
Atheroprotective potential of macrophage-derived phospholipid transfer protein in low-density lipoprotein receptor-deficient mice is overcome by apolipoprotein AI overexpression.
Phospholipid transfer protein is present in human atherosclerotic lesions and is expressed by macrophages and foam cells.
Cholesteryl ester transfer protein and phospholipid transfer protein have nonoverlapping functions in vivo.
A geriatric survey in general practice.
Smagris E, Gilyard S, BasuRay S, Cohen JC, Hobbs HH
The Journal of biological chemistry 2016 May 13;291(20):10659-76
The Journal of biological chemistry 2016 May 13;291(20):10659-76
Plasma phospholipid transfer protein, cholesteryl ester transfer protein and lecithin:cholesterol acyltransferase in end-stage renal disease (ESRD).
Pahl MV, Ni Z, Sepassi L, Moradi H, Vaziri ND
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2009 Aug;24(8):2541-6
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2009 Aug;24(8):2541-6
Control of cholesteryl ester transfer protein activity by sequestration of lipid transfer inhibitor protein in an inactive complex.
He Y, Greene DJ, Kinter M, Morton RE
Journal of lipid research 2008 Jul;49(7):1529-37
Journal of lipid research 2008 Jul;49(7):1529-37
Atheroprotective potential of macrophage-derived phospholipid transfer protein in low-density lipoprotein receptor-deficient mice is overcome by apolipoprotein AI overexpression.
Valenta DT, Ogier N, Bradshaw G, Black AS, Bonnet DJ, Lagrost L, Curtiss LK, Desrumaux CM
Arteriosclerosis, thrombosis, and vascular biology 2006 Jul;26(7):1572-8
Arteriosclerosis, thrombosis, and vascular biology 2006 Jul;26(7):1572-8
Phospholipid transfer protein is present in human atherosclerotic lesions and is expressed by macrophages and foam cells.
Desrumaux CM, Mak PA, Boisvert WA, Masson D, Stupack D, Jauhiainen M, Ehnholm C, Curtiss LK
Journal of lipid research 2003 Aug;44(8):1453-61
Journal of lipid research 2003 Aug;44(8):1453-61
Cholesteryl ester transfer protein and phospholipid transfer protein have nonoverlapping functions in vivo.
Kawano K, Qin SC, Lin M, Tall AR, Jiang XC
The Journal of biological chemistry 2000 Sep 22;275(38):29477-81
The Journal of biological chemistry 2000 Sep 22;275(38):29477-81
A geriatric survey in general practice.
Hay EH
The Practitioner 1976 Apr;216(1294):443-7
The Practitioner 1976 Apr;216(1294):443-7
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB